Maritime Pine Bark Extract Explained Simply
Maritime pine bark extract is a plant extract derived from the bark of the maritime pine. This page summarises in simple terms what human studies have shown and what remains open.
1. What It Is About
The extract is obtained from the bark of the French maritime pine, which grows on the Atlantic coast in southwestern France. The bark contains many plant pigments called proanthocyanidins. These belong to the polyphenols, a large group of plant substances. The body absorbs only a small portion of them; some are metabolised in the gut and then enter the bloodstream. Most studies used a standardised extract with a defined content of these plant substances; in the research, it is usually referred to as Pycnogenol®. Researchers typically measure the effects using blood parameters, for example the blood's ability to neutralise aggressive oxygen particles or the flow properties of the vessels. Such blood parameters are not the same as disease progression. In total, there are 54 controlled human studies; 'controlled' means there is a comparison group. In addition, there are observational studies, animal experiments and cell studies. The outcomes of the individual studies are detailed in the next section.
2. What Studies Show
The best-studied area is blood vessels. In one study, 16 healthy young men took an extract for two weeks. Afterwards, the vessels in their forearms dilated better in response to a specific stimulus; in the comparison group, which received a preparation without the plant substances, there was no change. An experiment with an inhibitor suggested that a natural messenger substance is involved in this process 2.
In people with narrowed coronary arteries—those supplying the heart muscle—the vascular function improved under the extract, while it slightly deteriorated in the comparison group 1. The measurement was based on how much an artery in the arm could dilate.
In a five-week study, 'good' HDL cholesterol increased and the upper blood pressure value decreased 4. The number of participants was small.
In knee osteoarthritis, 100 people were followed for three months. In the extract group, the use of painkillers decreased, while it increased in the comparison group 3. A smaller study with 33 people awaiting knee replacement surgery found fewer messenger substances in tissue samples that break down cartilage and promote inflammation 6. Neither study measured changes in the joint itself.
In a study of severely injured patients with brain injury, more people in the extract group survived after 28 days 5. This is a single finding from a complex treatment situation.
Gastrointestinal complaints occurred in the studies about as often as in the comparison groups.
3. What Remains Unclear
Many findings are based on blood parameters rather than disease progression. Whether the extract, for example, prevents heart attacks or strokes has not been demonstrated. Long-term studies following large groups are still lacking. Most studies are small, last only a few weeks and use different extracts. One study found no benefit for cardiovascular risk factors at all 7. Furthermore, many of the controlled studies originate from the environment of a manufacturer, which may limit the independence of the results. For gut health, bone density and memory, there are mostly observations or laboratory findings, but hardly any controlled studies. Little is also known about interactions with medications. The current state is: indications, but not yet confirmed.
4. What This Means in Everyday Life
The results show a recurring pattern: in several small studies, vascular function and individual blood parameters improved. This is not well established—several large, independent studies with the same measurement parameters would be needed to confirm it. Those following the research should consider two things: Does a study have a comparison group? And does it count disease events or only blood parameters? Blood parameters can improve without a change in disease progression. It is also important to consider who conducted the study, as many controlled studies come from the environment of a manufacturer. The next step would be to clarify whether the extract influences cardiovascular events or the progression of osteoarthritis with long-term use.
All details with study numbers and sources: detailed page on pine bark extract. For children: Pine bark extract for children.
Frequently Asked Questions
What exactly is maritime pine bark extract?
It is an extract from the bark of the French maritime pine. It contains many plant substances called proanthocyanidins. The studies usually use a standardised extract in which the content of these substances is fixed.
Can maritime pine bark extract lower blood pressure?
In a small study, the upper blood pressure value decreased after five weeks of intake. This value lacked a comparison group, and only a few people took part. Whether blood pressure changes permanently is therefore not clear.
Does the extract help with osteoarthritis?
In a study with 100 people, the use of painkillers decreased. In a smaller study, the activity of inflammatory and cartilage-degrading substances decreased. Changes in the joint itself were not measured. Whether joint wear progresses more slowly is therefore open.
Is the extract well tolerated?
In the studies, gastrointestinal complaints occurred about as often as in the comparison groups. Data on intake for more than six months are rare. Whether complaints accumulate with long-term intake is an open question.
Sources
- 1Enseleit F, Sudano I, Périat D, Winnik S, Wolfrum M, Flammer AJ et al. · 2012
- 2Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humansNishioka K, Hidaka T, Nakamura S, Umemura T, Jitsuiki D, Soga J et al. · 2007
- 3Cisár P, Jány R, Waczulíková I, Sumegová K, Muchová J, Vojtassák J et al. · 2008
- 4Valls RM, Llauradó E, Fernández-Castillejo S, Puiggrós F, Solà R, Arola L et al. · 2016
- 5Malekahmadi M, Shadnoush M, Islam SMS, Shirvani A, Pahlavani N, Gholizadeh Navashenaq J et al. · 2021
- 6Jessberger S, Högger P, Genest F, Salter DM, Seefried L · 2017
- 7Drieling RL, Gardner CD, Ma J, Ahn DK, Stafford RS · 2010
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.